Eosinophil Polymorphonuclear Leukocytes in TB: What We Know so Far

Senbagavalli Prakash Babu; Prakash B. Narasimhan; Subash Babu; Subash Babu

doi:10.3389/fimmu.2019.02639

Frontiers in Immunology (Nov 2019)

Eosinophil Polymorphonuclear Leukocytes in TB: What We Know so Far

Senbagavalli Prakash Babu,
Prakash B. Narasimhan,
Subash Babu,
Subash Babu

Affiliations

Senbagavalli Prakash Babu: Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, India
Prakash B. Narasimhan: Preventive and Social Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, India
Subash Babu: National Institute of Research in Tuberculosis (ICMR), Chennai, India
Subash Babu: Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases (NIH), Bethesda, MD, United States

DOI: https://doi.org/10.3389/fimmu.2019.02639
Journal volume & issue: Vol. 10

Abstract

Read online

Knowledge on the cellular immune responses to infection with Mycobacterium tuberculosis has improved drastically in recent years. Though eosinophils and hypereosinophilia are linked with the disease process of tuberculosis, there is paucity of information to prove the actual role played by these polymorphonuclear leukocytes. The aim of this review is to provide an overview of the existing literature on what is known so far about eosinophils and tuberculosis.

Published in Frontiers in Immunology

ISSN: 1664-3224 (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
Website: http://journal.frontiersin.org/journal/immunology

About the journal

Abstract

Keywords